Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA

Banchereau, 1998, Dendritic cells and the control of immunity, Nature, 392, 245, 10.1038/32588 Villadangos, 2007, Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo, Nat Rev Immunol, 7, 543, 10.1038/nri2103 Villadangos, 2007, Outside looking in: the inner workings of the cross-presentation pathway within dendritic cells, Trends Immunol, 28, 45, 10.1016/j.it.2006.12.008 Tang, 1992, Genetic immunization is a simple method for eliciting an immune response, Nature, 356, 152, 10.1038/356152a0 Kutzler, 2008, DNA vaccines: ready for prime time?, Nat Rev Genet, 9, 776, 10.1038/nrg2432 Ribas, 2000, Genetic immunotherapy for cancer, Oncologist, 5, 87, 10.1634/theoncologist.5-2-87 Ribas, 2000, Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells, J Immunother, 23, 59, 10.1097/00002371-200001000-00008 Gilboa, 2004, Cancer immunotherapy with mRNA-transfected dendritic cells, Immunol Rev, 199, 251, 10.1111/j.0105-2896.2004.00139.x Pascolo, 2008, Vaccination with messenger RNA (mRNA), Handb Exp Pharmacol, 221, 10.1007/978-3-540-72167-3_11 Weide, 2008, Plasmid DNA- and messenger RNA–based anti-cancer vaccination, Immunol Lett, 115, 33, 10.1016/j.imlet.2007.09.012 Gao, 1996, Potentiation of cationic liposome-mediated gene delivery by polycations, Biochemistry, 35, 1027, 10.1021/bi952436a Whitmore, 2001, Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses, Cancer Immunol Immunother, 50, 503, 10.1007/s002620100227 Li, 2006, Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells, Mol Pharm, 3, 579, 10.1021/mp060039w Li, 2006, Surface-modified LPD nanoparticles for tumor targeting, Ann N Y Acad Sci, 1082, 1, 10.1196/annals.1348.001 Hoerr, 2000, In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies, Eur J Immunol, 30, 1, 10.1002/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-# Mockey, 2007, Le Cam E, et al. mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes, Cancer Gene Ther, 14, 802, 10.1038/sj.cgt.7701072 Midoux, 2009, Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers, Br J Pharmacol, 157, 166, 10.1111/j.1476-5381.2009.00288.x Mevel, 2008, Novel neutral imidazole-lipophosphoramides for transfection assays, Chem Commun (Camb), 3124, 10.1039/b805226c Mevel, 2008, Synthesis and transfection activity of new cationic phosphoramidate lipids: high efficiency of an imidazolium derivative, Chembiochem, 9, 1462, 10.1002/cbic.200700727 Perche F, Gosset D, Mével M, Miramon ML, Yaouanc J, Pichon C, et al. Selective gene delivery in dendritic cells with mannosylated and histidylated lipopolyplexes. J Drug Target, epub ahead of print 23 July 2010 doi:10.3109/1061186X.2010.504262. Midoux, 1999, Efficient gene transfer by histidylated polylysine/pDNA complexes, Bioconjug Chem, 10, 406, 10.1021/bc9801070 Montier, 2004, Efficient gene transfer into human epithelial cell lines using glycosylated cationic carriers and neutral glycosylated co-lipids, Blood Cells Mol Dis, 32, 271, 10.1016/j.bcmd.2003.11.004 Heiser, 2000, Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro, J Immunol, 164, 5508, 10.4049/jimmunol.164.10.5508 Tuyaerts, 2003, Induction of influenza matrix protein 1 and melanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells, Cancer Gene Ther, 10, 696, 10.1038/sj.cgt.7700622 Mockey, 2006, mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with poly(A) chains in cis and in trans for a high protein expression level, Biochem Biophys Res Commun, 340, 1062, 10.1016/j.bbrc.2005.12.105 Shen, 1997, Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules, J Immunol, 158, 2723, 10.4049/jimmunol.158.6.2723 Delepine, 2003, Biodistribution study of phosphonolipids: a class of non-viral vectors efficient in mice lung-directed gene transfer, J Gene Med, 5, 600, 10.1002/jgm.385 Tomayko, 1989, Determination of subcutaneous tumor size in athymic (nude) mice, Cancer Chemother Pharmacol, 24, 148, 10.1007/BF00300234 Mevel, 2007, Dicationic lipophosphoramidates as DNA carriers, Bioconjug Chem, 18, 1604, 10.1021/bc070089z Lamarche, 2007, Lipophosphoramidates as lipidic part of lipospermines for gene delivery, Bioconjug Chem, 18, 1575, 10.1021/bc070070w Le Gall, 2010, A novel cationic lipophosphoramidate with di-unsaturated lipid chains: synthesis, physico-chemical and transfection activities, J Med Chem, 53, 1496, 10.1021/jm900897a Picquet, 2005, Cationic lipophosphoramidates and lipophosphoguanidines are very efficient for in vivo DNA delivery, Bioconjug Chem, 16, 1051, 10.1021/bc050097k Kawakami, 2000, Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes, Gene Ther, 7, 292, 10.1038/sj.gt.3301089 Hattori, 2004, Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice, Biochem Biophys Res Commun, 317, 992, 10.1016/j.bbrc.2004.03.141 Hattori, 2006, Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route, J Pharmacol Exp Ther, 318, 828, 10.1124/jpet.106.105098 Landi, 2007, High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer, J Leukoc Biol, 82, 849, 10.1189/jlb.0906561 Strobel, 2000, Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes, Gene Ther, 7, 2028, 10.1038/sj.gt.3301326 Ceppi, 2009, Genetic modification of murine dendritic cells by RNA transfection, Methods Mol Biol, 531, 145, 10.1007/978-1-59745-396-7_10 Boczkowski, 1996, Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo, J Exp Med, 184, 465, 10.1084/jem.184.2.465 Schuurhuis, 2009, In situ expression of tumor antigens by messenger RNA–electroporated dendritic cells in lymph nodes of melanoma patients, Cancer Res, 69, 2927, 10.1158/0008-5472.CAN-08-3920 Kyte, 2006, Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA, Cancer Gene Ther, 13, 905, 10.1038/sj.cgt.7700961 Wagstaff, 2007, Nucleocytoplasmic transport of DNA: enhancing non-viral gene transfer, Biochem J, 406, 185, 10.1042/BJ20070505 Mesika, 2005, Enhanced intracellular mobility and nuclear accumulation of DNA plasmids associated with a karyophilic protein, Hum Gene Ther, 16, 200, 10.1089/hum.2005.16.200 Breuzard, 2008, Nuclear delivery of NFκB-assisted DNA/polymer complexes: plasmid DNA quantitation by confocal laser scanning microscopy and evidence of nuclear polyplexes by FRET imaging, Nucleic Acids Res, 36, e71, 10.1093/nar/gkn287 Goncalves, 2009, An optimized extended DNA κB site that enhances plasmid DNA nuclear import and gene expression, J Gene Med, 11, 401, 10.1002/jgm.1312 Holtkamp, 2006, Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells, Blood, 108, 4009, 10.1182/blood-2006-04-015024 Un, 2010, Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy, Biomaterials, 31, 7813, 10.1016/j.biomaterials.2010.06.058 Lu, 2007, Development of an antigen-presenting cell–targeted DNA vaccine against melanoma by mannosylated liposomes, Biomaterials, 28, 3255, 10.1016/j.biomaterials.2007.03.028 Tanaka, 2002, Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma, Mol Ther, 5, 291, 10.1006/mthe.2002.0537 Rodriguez, 1998, DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination, J Virol, 72, 5174, 10.1128/JVI.72.6.5174-5181.1998